FDA Clearance Tracker · P970003-S197
Pulse, PulseDuo, DemiPulse, DemiPulseDuo, AspireHC, Aspire SR Generators.
Last checked: Nov 20, 2026Latest source record: Jul 28, 2016 (this decision)Source: openFDAMethods & limitations
Decided
Jul 28, 2016
Approved
Time to decision
86 days
Received May 3, 2016. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P970003-S197
- Device name
- Pulse, PulseDuo, DemiPulse, DemiPulseDuo, AspireHC, Aspire SR Generators.
- Applicant
- LivaNova USA, Inc.
- Applicant location
- Houston, TX
- Received
- May 3, 2016
- Decided
- Jul 28, 2016
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P970003
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for changes to the labeling to update stimulation dosing strategies and modify ECG filter settings.
Source documents
Other decisions for LivaNova USA, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P250013 · Decided Mar 18, 2026 · 327 days after receipt
Device type: Stimulator, hypoglossal nerve, implanted, apnea (MNQ) · Anesthesiology & Respiratory
4 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.